Menadiol Diphosphoric Acid

Summary

Menadiol Diphosphoric Acid (CHEMBL1201348) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 334.16 Da · C11H12O8P2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201348
Name	Menadiol Diphosphoric Acid
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	8556
Molecular formula	C11H12O8P2
Molecular weight	334.16
InChIKey	JTNHOVZOOVVGHI-UHFFFAOYSA-N

SMILES: CC1=C(C2=CC=CC=C2C(=C1)OP(=O)(O)O)OP(=O)(O)O

IUPAC name: (2-methyl-4-phosphonooxynaphthalen-1-yl) dihydrogen phosphate

Parent form; salt/anhydrous children: CHEMBL3989728

Patent coverage: 54 distinct patent families (361 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).